Infrajet 50 - Omstal Pharma

Increlex, a recombinant version of Insulin-Like Growth Factor 1 (IGF-1), is used to treat children with poor growth responses due to primary IGF-1 deficiency. It benefits those who do not produce enough IGF-1 naturally, despite standard growth hormone therapy. Mecasermin promotes the development of bone and muscle tissue by mimicking natural IGF-1, aiding in overcoming growth failure. Use requires close monitoring of glucose levels to prevent hypoglycemia, a common side effect during treatment.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Infrajet 50 by Omstal Pharma, consult with your doctor or healthcare professional.